NCT06386276 Surgical TReatment of Women With Deep ENDometriosis
| NCT ID | NCT06386276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Casa di Cura Privata 'Malzoni - Villa dei Platani' S.P.A. |
| Condition | Deep Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-10-11 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2023-10-11 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
TrEnd trial is aimed to collect data from consecutive patients undergoing segmental sigmoid colon/rectal resection for deep endometriosis. The main purpose of this project is to gather a large series of cases treated using standardized surgical procedures, allowing a precise evaluation of complications and long-term outcomes.
Eligibility Criteria
Inclusion Criteria: * age \>/= 18 years; * presence of deep endometriotic nodule(s) infiltrating the tunica muscularis of the sigmoid colon/rectum. Exclusion Criteria: * age \<18 years: * presence of coexisting inflammatory bowel disease; * patients who have received previous pelvic radiotherapy.
Contact & Investigator
Mario Malzoni, MD
PRINCIPAL INVESTIGATOR
malzonimario@gmail.com
Frequently Asked Questions
Who can join the NCT06386276 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Deep Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06386276 currently recruiting?
Yes, NCT06386276 is actively recruiting participants. Contact the research team at malzonimario@gmail.com for enrollment information.
Where is the NCT06386276 trial being conducted?
This trial is being conducted at Avellino, Italy.
Who is sponsoring the NCT06386276 clinical trial?
NCT06386276 is sponsored by Casa di Cura Privata 'Malzoni - Villa dei Platani' S.P.A.. The principal investigator is Mario Malzoni, MD at malzonimario@gmail.com. The trial plans to enroll 250 participants.